Target intelligence / Profile preview

Epithelial cell tight junction proteins (TJ protein)

Target
TJ protein
Molecular classification
Transmembrane adhesion protein (Claudins, Occludin, Junctional adhesion molecule family), Scaffolding/adaptor protein (e.g., Zonula occludens/ZO proteins), Marvel domain-containing protein (Occludin, Tricellulin), Immunoglobulin-like cell adhesion molecule (JAM family, Angulin family)
01

Overview

Tight junction proteins are a family of mostly transmembrane and associated cytosolic proteins that assemble into complexes at the apico-lateral border of epithelial cells, forming the tight junction. These proteins—including the claudins (over 27 members), occludin, JAMs, tricellulin, and zonula occludens—maintain a size- and charge-selective barrier for paracellular flux, regulate epithelial permeability and cell polarity, and serve as signaling hubs for cell differentiation and immune function[1][2][4][5][7]. Dysfunction or altered expression of tight junction proteins is implicated in many diseases, making them a significant focus for research and therapeutic modulation[2][4][5]. Note: The term "Epithelial cell tight junction proteins" is too broad and informal to be a canonical target name; for structured data, specify the individual protein (e.g., "Claudin-1," "Occludin," or "Junctional adhesion molecule-A")[1][4][5][7].

Other names
Tight junction proteinsTJ proteinsParacellular barrier proteinsZonula occludens proteins (for associated cytosolic scaffolds)
02

Mechanism of action

Modulation of junctional structure and paracellular permeability via phosphorylation, cytoskeletal rearrangement, or altered expression/localization Targeting occludin, claudin, or JAM proteins to regulate barrier tightness Disruption by pathogens (e.g., by binding JAM-A)

03

Biological functions

Paracellular barrier and selective transportMaintenance of cell polarityRegulating permeability and tissue homeostasisCell signaling, differentiation, and proliferationImmune cell transmigration and host defense
04

Disease associations

Cancer (disrupted barrier facilitating metastasis and invasion)Inflammation (increased permeability)Infection (targeted disruption by pathogens)Neurodegenerative disease (blood-brain barrier dysfunction)Other (lactation defects, cardiovascular disease via endothelial dysfunction)
05

Safety considerations

Risk of barrier dysfunction leads to tissue leakage and inflammationAltered drug delivery and bioavailability due to variable barrier propertiesOff-target effects in non-epithelial tissues (blood-brain barrier, endothelia)
06

Interacting drugs

No FDA-approved drugs directly and specifically target tight junction proteins; modulators include agents that indirectly affect the barrier (e.g., glucocorticoids for airway diseases, lactogenic hormones, or experimental peptides and antibodies)

1 more in the full profile.

07

Biomarkers

Expression levels of claudin-1, occludin, JAM-A (often assessed in cancer, IBD, and tissue injury)ZO-1 localization (used as a marker of barrier integrity in histological studies)

Beyond the preview

Go deeper on Epithelial cell tight junction proteins (TJ protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial cell tight junction proteins (TJ protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call